CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 36 filers reported holding CYTOSORBENTS CORP in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,000 | -12.5% | 1,195 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | -11.1% | 1,195 | -40.9% | 0.00% | – |
| Q2 2016 | $9,000 | -18.2% | 2,022 | -27.6% | 0.00% | – |
| Q1 2016 | $11,000 | -31.2% | 2,794 | -3.9% | 0.00% | -100.0% |
| Q4 2015 | $16,000 | -30.4% | 2,906 | -18.6% | 0.00% | -50.0% |
| Q3 2015 | $23,000 | 0.0% | 3,569 | -6.6% | 0.00% | 0.0% |
| Q2 2015 | $23,000 | -65.2% | 3,822 | -23.3% | 0.00% | -60.0% |
| Q1 2015 | $66,000 | – | 4,985 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |